Target intelligence / Profile preview

Fizzy-related protein homolog (FZR1)

Target
FZR1
Molecular classification
Enzyme (E3 ubiquitin-protein ligase complex co-activator; substrate adaptor of anaphase-promoting complex/cyclosome (APC/C)), Cell cycle regulatory adaptor protein
01

Overview

Fizzy-related protein homolog (FZR1) is a substrate-specific adaptor protein for the anaphase-promoting complex/cyclosome (APC/C), playing an essential role in the controlled degradation of cell cycle regulators to ensure proper progression through mitosis and maintenance of genomic stability[1][2]. FZR1 associates with APC/C following CDC20 dissociation in late mitosis and promotes the ubiquitination of substrates such as cyclin B and securin, allowing correct anaphase initiation and mitotic exit[1][2]. Phosphorylation cycles regulate FZR1 activity, especially at the G1/S checkpoint and in response to DNA damage, where it is implicated in halting mitotic progression and promoting DNA repair[1][2]. Beyond its cell cycle functions, FZR1/CDH1 regulates neurodevelopment, controlling neuronal survival, axonal outgrowth, and synapse function[4]. Pathogenic mutations in FZR1 result in developmental and epileptic encephalopathy and associations with neurodevelopmental disorders, while altered expression or dysregulation is implicated in cancer and other diseases[2][4]. Research targeting FZR1 for therapeutics is ongoing, with diagnostic and prognostic biomarker potential in oncology and neurology[2][4].

Other names
CDH1FYRFZRKIAA1242HCDH1CDC20CCDC20-like protein 1Cdh1/Hct1 homologCDC20 homolog 1DEE109CDC20-like 1bHCDHfizzy/cell division cycle 20 related 1FZR2retina aberrant in pattern (rap), in Drosophila
02

Mechanism of action

Modulators of FZR1 would affect APC/C-mediated ubiquitination leading to altered degradation of cell cycle regulators such as cyclin B and securin, potentially inducing cell-cycle arrest or apoptosis in cancer cells[2]. Indirect regulation of DNA damage response via partnership with p53 and ubiquitination of downstream effectors[1][2].

03

Biological functions

Cell cycle regulation (especially transition from metaphase to anaphase)APC/C-dependent protein degradationG1/S transition checkpoint controlDNA damage response and checkpoint signalingNeurodevelopment (post-mitotic neuronal function, neuronal survival, axonal growth, synapse formation)Mitotic and spindle checkpoint control (spindle assembly checkpoint, mitotic checkpoint complex)
04

Disease associations

Cancer (dysregulation leads to uncontrolled proliferation)Developmental and epileptic encephalopathyNeurodevelopmental disordersNeurodegenerative diseaseMicrocephaly
05

Safety considerations

Potential challenge in targeting FZR1 due to its critical role in normal cell division and neurodevelopment: inhibition could cause toxicity (e.g., developmental defects, neurotoxicity)Tumor suppressor function suggests risk of adverse effects if suppressed in normal tissues.
06

Interacting drugs

None specifically listed in current search results.[1][2][3] No approved drugs directly target FZR1 as of 2024; research is ongoing for cancer and other potential indications.
07

Biomarkers

Altered FZR1 expression and function proposed as diagnostic and prognostic biomarkers in cancerFZR1 protein levels may be used to monitor DNA damage response or cell cycle status in certain diseases

Beyond the preview

Go deeper on Fizzy-related protein homolog (FZR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fizzy-related protein homolog (FZR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call